Paul F. Resnick

All filings by Paul F. Resnick on record concern Mabvax Therapeutics Holdings, Inc. We count 5 filings; the first trade dates from 8 January 2018 and the latest from 16 January 2018.

On the market, this insider has only sold: 4 sales, €9,212 in total. Other entries cover 1 option exercise.

The record was last updated on 18 January 2018 with an open-market sale (€2,303) in Mabvax Therapeutics Holdings, Inc. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.